BusinessNeos Therapeutics Reports First Quarter 2017 Financial ResultsBy Nasdaq OMXMay 9, 2017, 11:01 AM UTC
BusinessNeos Therapeutics Reports First Quarter 2017 Financial ResultsBy Nasdaq OMXMay 9, 2017, 11:01 AM UTC
BusinessNeos Therapeutics to Host First Quarter 2017 Financial Results Conference Call on May 9, 2017By Nasdaq OMXMay 2, 2017, 11:31 AM UTC
BusinessNeos Therapeutics to Host First Quarter 2017 Financial Results Conference Call on May 9, 2017By Nasdaq OMXMay 2, 2017, 11:31 AM UTC
BusinessNeos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial ResultsBy Nasdaq OMXMar 14, 2017, 11:00 AM UTC
BusinessNeos Therapeutics Submits NDA for Amphetamine Extended-Release Liquid Suspension Drug Candidate, NT-0201, for the Treatment of ADHDBy Nasdaq OMXNov 17, 2016, 1:00 PM UTC
